1. Individual targeted agents to be searched.
Axitinib |
Bevacizumab |
Dovitinib |
Erlotinib |
Everolimus |
Lapatinib |
Pazopanib |
Sorafenib |
Sunitinib |
Temsirolimus |
Tivozanib |
Other agents identified during search |
Axitinib |
Bevacizumab |
Dovitinib |
Erlotinib |
Everolimus |
Lapatinib |
Pazopanib |
Sorafenib |
Sunitinib |
Temsirolimus |
Tivozanib |
Other agents identified during search |